2020-10-14 | Purchase | Kronos Bio, Inc. KRON | director | | $19.00 | $2.88M | -14.59% | |
2018-12-03 | Sale | Gilead Sciences, Inc. GILD | director | | $71.20 | $7.12M | -5.34% | |
2018-11-01 | Sale | Gilead Sciences, Inc. GILD | director | | $69.55 | $6.96M | -4.29% | |
2018-10-01 | Sale | Gilead Sciences, Inc. GILD | director | | $78.04 | $7.8M | -13.15% | |
2018-09-04 | Sale | Gilead Sciences, Inc. GILD | director | | $74.16 | $7.42M | -7.74% | |
2018-08-01 | Sale | Gilead Sciences, Inc. GILD | director | | $50.73 | $5.07M | -11.33% | |
2018-07-02 | Sale | Gilead Sciences, Inc. GILD | director | | $70.81 | $7.08M | -2.69% | |
2018-06-01 | Sale | Gilead Sciences, Inc. GILD | director | | $45.87 | $4.59M | +2.92% | |
2018-05-01 | Sale | Gilead Sciences, Inc. GILD | director | | $47.90 | $4.79M | -3.13% | |
2018-04-02 | Sale | Gilead Sciences, Inc. GILD | director | | $73.14 | $7.31M | -2.26% | |
2018-03-01 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $78.65 | $7.86M | -6.35% | |
2018-02-01 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $83.56 | $8.36M | -11.36% | |
2018-01-02 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $73.62 | $7.36M | +1.14% | |
2017-12-01 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $74.98 | $11M | +0.4% | |
2017-11-01 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $75.13 | $11.02M | +1.06% | |
2017-10-02 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $82.56 | $12.11M | -8.9% | |
2017-09-01 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $83.11 | $12.19M | -7.99% | |
2017-08-01 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $48.72 | $7.14M | +0.82% | |
2017-07-03 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $46.29 | $6.79M | +6.57% | |
2017-06-01 | Sale | Gilead Sciences, Inc. GILD | Executive Chairman | | $43.41 | $6.37M | +17.53% | |